Fund Overview of Mirae Asset Healthcare Fund Regular-idcw
-
₹2,908.2 CrAUM
-
₹23.29NAV
-
1.92%Expense Ratio
-
EquityFund Category
Returns of Mirae Asset Healthcare Fund Regular-idcw
| Tenure | Absolute(%) | Annualised(%) | Category Average(%) |
|---|---|---|---|
| 3 Months | 1.60% | NA | 6.12% |
| 6 Months | 14.07% | NA | 12.92% |
| 1 Year | -0.12% | -0.12% | 6.04% |
| 2 Years | 52.18% | 23.36% | 24.93% |
| 3 Years | 78.02% | 21.20% | 25.71% |
| 5 Years | 119.79% | 17.06% | 19.91% |
| 7 Years | 274.17% | 20.74% | NA |
Dividends are declared by the fund house based on the income generated from the underlying assets. While many mutual funds distribute dividends annually, the payout frequency ultimately depends on the fund house’s decision
Asset Allocation
equities
99.72%debt instruments
0.01%other assets or cash equivalents
0.27%Mirae Asset Healthcare Fund Regular-idcw is one Equity mutual fund offered by Mirae Asset Mutual Fund. Launched on 02 Jul 2018, the fund aims To generate long term capital appreciation. Investments in equity and equity related securities of companies benefitting directly or indirectly in Healthcare and allied sectors in India. It manages assets worth ₹2,908.2 crore as on Thu Jul 31, 2025. The expense ratio stands at 1.92%. Fund Manager Manager Education Fund Manager Manager EducationAbout Mirae Asset Healthcare Fund Regular-idcw
The portfolio allocation consists of 99.72% in equities, 0.01% in debt instruments, 0.27% in other assets or cash equivalents.Managed by Vrijesh Kasera, it has delivered a return of -0.12% in the last year, a total return since inception of 20.55%.
The latest dividend was declared on 28 Jan 2026 at 19.20% of face value.
Considering investment horizon investors may compare best sip as part of the long-term financial strategy.
Key Metrics of Mirae Asset Healthcare Fund Regular-idcw
-
Standard Deviation16.36%
-
Sharpe Ratio0.86%
-
Alpha-2.88%
-
Beta1.00%
Fund Details
|
|
Top Performing Mutual Funds
| Fund Names | AUM (Cr) | 1M | 3M | 1Yr | 3Yr | 5Yr |
|---|---|---|---|---|---|---|
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct - Growth |
₹6,104 | -0.17% | -3.70% | 11.10% | 29.16% | 18.03% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth |
₹6,104 | -0.21% | -3.88% | 10.20% | 28.07% | 17.00% |
| Aditya Birla Sun Life Pharma & Healthcare Fund Direct-growth |
₹872 | 2.08% | 2.63% | 13.48% | 26.36% | 16.00% |
| Aditya Birla Sun Life Pharma & Healthcare Fund Regular-growth |
₹872 | 1.98% | 2.28% | 11.98% | 24.68% | 14.39% |
More funds from Mirae Asset Mutual Fund
| Fund Names | AUM (Cr) | 1M | 3M | 6M | 1Yr | 3Yr |
|---|---|---|---|---|---|---|
|
Mirae Asset Healthcare Fund Regular - Growth
|
₹2,908 | 3.89% | 3.56% | 0.92% | 14.75% | 25.79% |
|
Mirae Asset Healthcare Fund Direct - Growth
|
₹2,908 | 4.00% | 3.93% | 1.65% | 16.41% | 27.64% |
|
Mirae Asset Healthcare Fund Direct-idcw
|
₹2,908 | 4.00% | 3.93% | 1.65% | 16.41% | 27.64% |
Mutual Fund Calculator
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 29
- 31
- 32
- 33
- 34
- 36
- 37
- 38
- 39
- 40
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 30
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 29
- 31
- 32
- 33
- 34
- 36
- 37
- 38
- 39
- 40
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 30
Top Mutual Funds
| Fund Names | AUM (Cr) | NAV | 3Yr | 5Yr | 10Yr |
|---|---|---|---|---|---|
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth |
₹6,104 | ₹38.45 | 28.07% | 17.00% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct - Growth |
₹6,104 | ₹41.64 | 29.16% | 18.03% | - |
| Aditya Birla Sun Life Pharma & Healthcare Fund Direct-growth |
₹872 | ₹34.77 | 26.36% | 16.00% | - |
| Aditya Birla Sun Life Pharma & Healthcare Fund Regular-growth |
₹872 | ₹31.40 | 24.68% | 14.39% | - |
| ICICI Prudential Nifty Healthcare Etf - Growth |
₹146 | ₹153.25 | 26.75% | - | - |
| ICICI Prudential Nifty Pharma Index Fund Direct - Growth |
₹95 | ₹18.06 | 25.67% | - | - |
| ICICI Prudential Nifty Pharma Index Fund - Growth |
₹95 | ₹17.70 | 24.88% | - | - |
| Aditya Birla Sun Life Nifty Healthcare Etf-growth |
₹37 | ₹15.37 | 26.92% | - | - |
Detailed Portfolio
| Stocks | Sector | % of Holding | Value |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | Healthcare | 13.06% | ₹367.13 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 12.44% | ₹344.70 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 12.01% | ₹338.89 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 12.01% | ₹338.89 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 11.77% | ₹334.73 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 12.11% | ₹319.76 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 11.57% | ₹319.56 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 11.57% | ₹319.56 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 10.74% | ₹312.23 Cr |
| Divi's Laboratories Ltd | Healthcare | 8.88% | ₹250.44 Cr |
| Divi's Laboratories Ltd | Healthcare | 8.88% | ₹250.44 Cr |
| Divi's Laboratories Ltd | Healthcare | 8.56% | ₹240.74 Cr |
| Divi's Laboratories Ltd | Healthcare | 8.57% | ₹237.60 Cr |
| Divi's Laboratories Ltd | Healthcare | 8.02% | ₹233.27 Cr |
| Divi's Laboratories Ltd | Healthcare | 8.16% | ₹232.10 Cr |
| Divi's Laboratories Ltd | Healthcare | 8.52% | ₹224.90 Cr |
| Divi's Laboratories Ltd | Healthcare | 7.76% | ₹214.31 Cr |
| Divi's Laboratories Ltd | Healthcare | 7.76% | ₹214.31 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 7.24% | ₹210.43 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 6.93% | ₹197.12 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 6.97% | ₹192.54 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 6.97% | ₹192.54 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 6.91% | ₹191.52 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 6.63% | ₹188.56 Cr |
| Aurobindo Pharma Ltd | Healthcare | 6.41% | ₹186.48 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 7.00% | ₹184.67 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 6.51% | ₹183.15 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 6.38% | ₹181.30 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 6.41% | ₹180.81 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 6.41% | ₹180.81 Cr |
| Cipla Ltd | Healthcare | 6.11% | ₹177.70 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 6.21% | ₹175.16 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 6.21% | ₹175.16 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 5.98% | ₹173.99 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 6.23% | ₹171.92 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 6.23% | ₹171.92 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 5.95% | ₹167.28 Cr |
| Cipla Ltd | Healthcare | 6.03% | ₹166.58 Cr |
| Cipla Ltd | Healthcare | 6.03% | ₹166.58 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 6.21% | ₹163.95 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 5.80% | ₹160.60 Cr |
| Cipla Ltd | Healthcare | 5.54% | ₹155.90 Cr |
| Cipla Ltd | Healthcare | 5.55% | ₹153.86 Cr |
| Cipla Ltd | Healthcare | 5.42% | ₹152.84 Cr |
| Cipla Ltd | Healthcare | 5.42% | ₹152.84 Cr |
| Lupin Ltd | Healthcare | 5.15% | ₹146.44 Cr |
| Lupin Ltd | Healthcare | 5.54% | ₹146.21 Cr |
| Lupin Ltd | Healthcare | 5.18% | ₹145.58 Cr |
| Lupin Ltd | Healthcare | 5.23% | ₹144.85 Cr |
| Lupin Ltd | Healthcare | 4.94% | ₹143.56 Cr |
| Lupin Ltd | Healthcare | 5.07% | ₹143.17 Cr |
| Lupin Ltd | Healthcare | 5.07% | ₹143.17 Cr |
| Lupin Ltd | Healthcare | 5.05% | ₹139.37 Cr |
| Lupin Ltd | Healthcare | 5.05% | ₹139.37 Cr |
| Cipla Ltd | Healthcare | 4.83% | ₹137.26 Cr |
| Cipla Ltd | Healthcare | 5.11% | ₹134.79 Cr |
| Fortis Healthcare Ltd | Healthcare | 4.33% | ₹122.06 Cr |
| Fortis Healthcare Ltd | Healthcare | 4.33% | ₹122.06 Cr |
| Fortis Healthcare Ltd | Healthcare | 4.29% | ₹121.89 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 4.28% | ₹121.75 Cr |
| Aurobindo Pharma Ltd | Healthcare | 4.33% | ₹121.74 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 4.34% | ₹120.34 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 4.13% | ₹120.23 Cr |
| Aurobindo Pharma Ltd | Healthcare | 4.33% | ₹119.51 Cr |
| Aurobindo Pharma Ltd | Healthcare | 4.33% | ₹119.51 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 4.24% | ₹119.14 Cr |
| Fortis Healthcare Ltd | Healthcare | 4.21% | ₹118.39 Cr |
| Aurobindo Pharma Ltd | Healthcare | 4.24% | ₹117.41 Cr |
| Fortis Healthcare Ltd | Healthcare | 4.22% | ₹116.96 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 4.19% | ₹115.82 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 4.19% | ₹115.82 Cr |
| Fortis Healthcare Ltd | Healthcare | 4.19% | ₹115.71 Cr |
| Fortis Healthcare Ltd | Healthcare | 4.19% | ₹115.71 Cr |
| Aurobindo Pharma Ltd | Healthcare | 4.09% | ₹115.31 Cr |
| Aurobindo Pharma Ltd | Healthcare | 4.09% | ₹115.31 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 4.37% | ₹115.29 Cr |
| Aurobindo Pharma Ltd | Healthcare | 4.33% | ₹114.42 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 4.02% | ₹113.35 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 4.02% | ₹113.35 Cr |
| Fortis Healthcare Ltd | Healthcare | 4.27% | ₹112.66 Cr |
| Aurobindo Pharma Ltd | Healthcare | 3.92% | ₹111.34 Cr |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | 3.81% | ₹110.85 Cr |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | 3.79% | ₹107.67 Cr |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | 3.77% | ₹106.40 Cr |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | 3.77% | ₹106.40 Cr |
| Ipca Laboratories Ltd | Healthcare | 3.74% | ₹105.16 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 3.56% | ₹103.63 Cr |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | 3.74% | ₹103.32 Cr |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | 3.74% | ₹103.32 Cr |
| Fortis Healthcare Ltd | Healthcare | 3.52% | ₹102.30 Cr |
| Laurus Labs Ltd | Healthcare | 3.56% | ₹101.21 Cr |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | 3.59% | ₹101.10 Cr |
| Ipca Laboratories Ltd | Healthcare | 3.56% | ₹100.45 Cr |
| Ipca Laboratories Ltd | Healthcare | 3.56% | ₹100.45 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 3.48% | ₹98.22 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 3.48% | ₹98.22 Cr |
| Ipca Laboratories Ltd | Healthcare | 3.49% | ₹96.44 Cr |
| Ipca Laboratories Ltd | Healthcare | 3.49% | ₹96.44 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 3.43% | ₹96.40 Cr |
| Ipca Laboratories Ltd | Healthcare | 3.31% | ₹96.32 Cr |
| Ipca Laboratories Ltd | Healthcare | 3.46% | ₹95.85 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 3.62% | ₹95.46 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 3.33% | ₹94.82 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 3.40% | ₹93.95 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 3.40% | ₹93.95 Cr |
| Alkem Laboratories Ltd | Healthcare | 3.30% | ₹92.89 Cr |
| Alkem Laboratories Ltd | Healthcare | 3.51% | ₹92.77 Cr |
| Alkem Laboratories Ltd | Healthcare | 3.24% | ₹92.15 Cr |
| Laurus Labs Ltd | Healthcare | 3.32% | ₹92.05 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 3.30% | ₹91.24 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 3.30% | ₹91.24 Cr |
| Eris Lifesciences Ltd | Healthcare | 3.22% | ₹90.46 Cr |
| Ipca Laboratories Ltd | Healthcare | 3.18% | ₹90.32 Cr |
| Eris Lifesciences Ltd | Healthcare | 3.20% | ₹90.25 Cr |
| Eris Lifesciences Ltd | Healthcare | 3.20% | ₹90.25 Cr |
| Alkem Laboratories Ltd | Healthcare | 3.19% | ₹89.97 Cr |
| Alkem Laboratories Ltd | Healthcare | 3.19% | ₹89.97 Cr |
| Alkem Laboratories Ltd | Healthcare | 3.25% | ₹89.97 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 3.22% | ₹89.36 Cr |
| Laurus Labs Ltd | Healthcare | 3.38% | ₹89.33 Cr |
| Ipca Laboratories Ltd | Healthcare | 3.37% | ₹89.09 Cr |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | 3.17% | ₹87.95 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 3.01% | ₹87.63 Cr |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | 3.31% | ₹87.25 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 3.10% | ₹85.86 Cr |
| Laurus Labs Ltd | Healthcare | 3.05% | ₹85.68 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 3.24% | ₹85.44 Cr |
| Eris Lifesciences Ltd | Healthcare | 3.08% | ₹85.37 Cr |
| Eris Lifesciences Ltd | Healthcare | 3.01% | ₹83.14 Cr |
| Eris Lifesciences Ltd | Healthcare | 3.01% | ₹83.14 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 3.00% | ₹83.05 Cr |
| Sai Life Sciences Ltd. | Healthcare | 2.89% | ₹82.10 Cr |
| Onesource Specialty Pharma Ltd | Healthcare | 2.93% | ₹81.26 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 2.78% | ₹80.72 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 2.85% | ₹80.26 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 3.03% | ₹79.98 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 2.83% | ₹79.50 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 2.73% | ₹79.41 Cr |
| Laurus Labs Ltd | Healthcare | 2.81% | ₹79.22 Cr |
| Laurus Labs Ltd | Healthcare | 2.81% | ₹79.22 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 2.77% | ₹78.20 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 2.77% | ₹78.20 Cr |
| Eris Lifesciences Ltd | Healthcare | 2.95% | ₹77.99 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 2.81% | ₹77.73 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 2.81% | ₹77.73 Cr |
| Alkem Laboratories Ltd | Healthcare | 2.80% | ₹77.25 Cr |
| Alkem Laboratories Ltd | Healthcare | 2.80% | ₹77.25 Cr |
| Eris Lifesciences Ltd | Healthcare | 2.71% | ₹77.02 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 2.72% | ₹76.80 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 2.72% | ₹76.80 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 2.78% | ₹76.74 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 2.78% | ₹76.74 Cr |
| Onesource Specialty Pharma Ltd | Healthcare | 2.70% | ₹76.30 Cr |
| Onesource Specialty Pharma Ltd | Healthcare | 2.70% | ₹76.30 Cr |
| Onesource Specialty Pharma Ltd | Healthcare | 2.74% | ₹75.74 Cr |
| Onesource Specialty Pharma Ltd | Healthcare | 2.74% | ₹75.74 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 2.68% | ₹75.51 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 2.68% | ₹75.51 Cr |
| Sai Life Sciences Ltd. | Healthcare | 2.69% | ₹74.61 Cr |
| Onesource Specialty Pharma Ltd | Healthcare | 2.51% | ₹72.95 Cr |
| Sai Life Sciences Ltd. | Healthcare | 2.58% | ₹72.64 Cr |
| Sai Life Sciences Ltd. | Healthcare | 2.56% | ₹72.21 Cr |
| Sai Life Sciences Ltd. | Healthcare | 2.56% | ₹72.21 Cr |
| Alkem Laboratories Ltd | Healthcare | 2.46% | ₹71.64 Cr |
| Sai Life Sciences Ltd. | Healthcare | 2.71% | ₹71.52 Cr |
| Onesource Specialty Pharma Ltd | Healthcare | 2.43% | ₹69.06 Cr |
| Onesource Specialty Pharma Ltd | Healthcare | 2.45% | ₹68.77 Cr |
| Sai Life Sciences Ltd. | Healthcare | 2.45% | ₹67.69 Cr |
| Sai Life Sciences Ltd. | Healthcare | 2.45% | ₹67.69 Cr |
| Gland Pharma Ltd | Healthcare | 2.33% | ₹67.65 Cr |
| Laurus Labs Ltd | Healthcare | 2.29% | ₹63.20 Cr |
| Laurus Labs Ltd | Healthcare | 2.29% | ₹63.20 Cr |
| Onesource Specialty Pharma Ltd | Healthcare | 2.32% | ₹61.25 Cr |
| Eris Lifesciences Ltd | Healthcare | 2.02% | ₹58.79 Cr |
| Wockhardt Ltd | Healthcare | 1.96% | ₹56.92 Cr |
| Laurus Labs Ltd | Healthcare | 1.88% | ₹54.66 Cr |
| Mankind Pharma Ltd. | Healthcare | 1.93% | ₹54.24 Cr |
| Gland Pharma Ltd | Healthcare | 2.04% | ₹53.85 Cr |
| Gland Pharma Ltd | Healthcare | 1.87% | ₹53.14 Cr |
| Mankind Pharma Ltd. | Healthcare | 1.91% | ₹52.92 Cr |
| Mankind Pharma Ltd. | Healthcare | 1.80% | ₹52.48 Cr |
| Sai Life Sciences Ltd. | Healthcare | 1.80% | ₹52.26 Cr |
| Wockhardt Ltd | Healthcare | 1.87% | ₹51.75 Cr |
| Wockhardt Ltd | Healthcare | 1.87% | ₹51.75 Cr |
| Mankind Pharma Ltd. | Healthcare | 1.81% | ₹51.46 Cr |
| Gland Pharma Ltd | Healthcare | 1.81% | ₹50.21 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 1.78% | ₹50.11 Cr |
| Dr. Lal Pathlabs Ltd | Healthcare | 1.71% | ₹48.68 Cr |
| Mankind Pharma Ltd. | Healthcare | 1.84% | ₹48.63 Cr |
| Gland Pharma Ltd | Healthcare | 1.70% | ₹47.79 Cr |
| Gland Pharma Ltd | Healthcare | 1.70% | ₹46.82 Cr |
| Gland Pharma Ltd | Healthcare | 1.70% | ₹46.82 Cr |
| Gland Pharma Ltd | Healthcare | 1.61% | ₹45.35 Cr |
| Gland Pharma Ltd | Healthcare | 1.61% | ₹45.35 Cr |
| Mankind Pharma Ltd. | Healthcare | 1.62% | ₹44.68 Cr |
| Mankind Pharma Ltd. | Healthcare | 1.62% | ₹44.68 Cr |
| Mankind Pharma Ltd. | Healthcare | 1.55% | ₹43.73 Cr |
| Mankind Pharma Ltd. | Healthcare | 1.55% | ₹43.73 Cr |
| Biocon Ltd | Healthcare | 1.44% | ₹40.99 Cr |
| Anthem Biosciences Ltd. | Healthcare | 1.45% | ₹40.06 Cr |
| Anthem Biosciences Ltd. | Healthcare | 1.45% | ₹40.06 Cr |
| Anthem Biosciences Ltd. | Healthcare | 1.37% | ₹39.96 Cr |
| Anthem Biosciences Ltd. | Healthcare | 1.32% | ₹37.37 Cr |
| Anthem Biosciences Ltd. | Healthcare | 1.32% | ₹37.37 Cr |
| Anthem Biosciences Ltd. | Healthcare | 1.30% | ₹36.91 Cr |
| Wockhardt Ltd | Healthcare | 1.28% | ₹36.06 Cr |
| Wockhardt Ltd | Healthcare | 1.28% | ₹36.06 Cr |
| Anthem Biosciences Ltd. | Healthcare | 1.24% | ₹34.29 Cr |
| Anthem Biosciences Ltd. | Healthcare | 1.19% | ₹33.41 Cr |
| Anthem Biosciences Ltd. | Healthcare | 1.19% | ₹31.54 Cr |
| Biocon Ltd | Healthcare | 1.01% | ₹29.26 Cr |
| Rubicon Research Ltd. | 1.02% | ₹29.09 Cr | |
| Biocon Ltd | Healthcare | 1.04% | ₹27.57 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 0.99% | ₹27.38 Cr |
| Dr. Lal Pathlabs Ltd | Healthcare | 1.02% | ₹27.01 Cr |
| Rubicon Research Ltd. | 0.97% | ₹25.51 Cr | |
| Biocon Ltd | Healthcare | 0.92% | ₹25.49 Cr |
| Biocon Ltd | Healthcare | 0.92% | ₹25.49 Cr |
| Rubicon Research Ltd. | 0.92% | ₹25.38 Cr | |
| Alembic Pharmaceuticals Ltd | Healthcare | 0.87% | ₹25.37 Cr |
| Sagility India Ltd. | Industrials | 0.84% | ₹24.52 Cr |
| Rubicon Research Ltd. | 0.87% | ₹24.45 Cr | |
| Rubicon Research Ltd. | 0.82% | ₹23.04 Cr | |
| Rubicon Research Ltd. | 0.82% | ₹23.04 Cr | |
| Deepak Nitrite Ltd | Materials | 0.79% | ₹22.85 Cr |
| Deepak Nitrite Ltd | Materials | 0.83% | ₹22.79 Cr |
| Deepak Nitrite Ltd | Materials | 0.83% | ₹22.79 Cr |
| Sagility India Ltd. | Industrials | 0.81% | ₹22.44 Cr |
| Sagility India Ltd. | Industrials | 0.81% | ₹22.44 Cr |
| Repo | Unspecified | 0.78% | ₹21.97 Cr |
| Repo | Unspecified | 0.78% | ₹21.97 Cr |
| Deepak Nitrite Ltd | Materials | 0.78% | ₹21.50 Cr |
| Deepak Nitrite Ltd | Materials | 0.76% | ₹21.46 Cr |
| Deepak Nitrite Ltd | Materials | 0.76% | ₹21.46 Cr |
| Repo | Unspecified | 0.73% | ₹20.90 Cr |
| Deepak Nitrite Ltd | Materials | 0.69% | ₹19.35 Cr |
| Repo | Unspecified | 0.68% | ₹18.87 Cr |
| Sudeep Pharma Ltd. | 0.61% | ₹17.37 Cr | |
| Dr. Lal Pathlabs Ltd | Healthcare | 0.62% | ₹17.23 Cr |
| Laxmi Dental Ltd. | Healthcare | 0.59% | ₹17.18 Cr |
| Sagility India Ltd. | Industrials | 0.59% | ₹16.60 Cr |
| Sagility India Ltd. | Industrials | 0.59% | ₹16.60 Cr |
| Sudeep Pharma Ltd. | 0.63% | ₹16.56 Cr | |
| Sagility India Ltd. | Industrials | 0.59% | ₹16.44 Cr |
| Syngene International Ltd | Healthcare | 0.56% | ₹16.22 Cr |
| Corona Remedies Ltd. | 0.58% | ₹16.20 Cr | |
| Neogen Chemicals Ltd | Materials | 0.55% | ₹15.87 Cr |
| Sudeep Pharma Ltd. | 0.56% | ₹15.86 Cr | |
| Sagility India Ltd. | Industrials | 0.56% | ₹15.82 Cr |
| Sagility India Ltd. | Industrials | 0.60% | ₹15.78 Cr |
| Neogen Chemicals Ltd | Materials | 0.56% | ₹15.45 Cr |
| Neogen Chemicals Ltd | Materials | 0.56% | ₹15.45 Cr |
| Neogen Chemicals Ltd | Materials | 0.53% | ₹15.08 Cr |
| Deepak Nitrite Ltd | Materials | 0.57% | ₹15.04 Cr |
| Neogen Chemicals Ltd | Materials | 0.53% | ₹14.85 Cr |
| Neogen Chemicals Ltd | Materials | 0.53% | ₹14.85 Cr |
| Syngene International Ltd | Healthcare | 0.53% | ₹14.79 Cr |
| Syngene International Ltd | Healthcare | 0.52% | ₹14.77 Cr |
| Syngene International Ltd | Healthcare | 0.52% | ₹14.77 Cr |
| Syngene International Ltd | Healthcare | 0.52% | ₹14.73 Cr |
| Sagility India Ltd. | Industrials | 0.52% | ₹14.67 Cr |
| Deepak Nitrite Ltd | Materials | 0.51% | ₹14.47 Cr |
| Syngene International Ltd | Healthcare | 0.51% | ₹14.15 Cr |
| Syngene International Ltd | Healthcare | 0.51% | ₹14.15 Cr |
| Repo | Unspecified | 0.50% | ₹14.00 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 0.49% | ₹13.95 Cr |
| Repo | Unspecified | 0.46% | ₹13.31 Cr |
| Laxmi Dental Ltd. | Healthcare | 0.48% | ₹13.24 Cr |
| Laxmi Dental Ltd. | Healthcare | 0.48% | ₹13.24 Cr |
| Laxmi Dental Ltd. | Healthcare | 0.45% | ₹12.79 Cr |
| Laxmi Dental Ltd. | Healthcare | 0.45% | ₹12.79 Cr |
| Repo | Unspecified | 0.48% | ₹12.58 Cr |
| Neogen Chemicals Ltd | Materials | 0.47% | ₹12.53 Cr |
| Sudeep Pharma Ltd. | 0.45% | ₹12.35 Cr | |
| Neogen Chemicals Ltd | Materials | 0.44% | ₹12.19 Cr |
| Neogen Chemicals Ltd | Materials | 0.41% | ₹11.59 Cr |
| Corona Remedies Ltd. | 0.35% | ₹10.04 Cr | |
| Corona Remedies Ltd. | 0.35% | ₹9.36 Cr | |
| Laxmi Dental Ltd. | Healthcare | 0.32% | ₹8.91 Cr |
| Wockhardt Ltd | Healthcare | 0.30% | ₹8.41 Cr |
| Repo | Unspecified | 0.25% | ₹7.00 Cr |
| Repo | Unspecified | 0.25% | ₹7.00 Cr |
| Wockhardt Ltd | Healthcare | 0.11% | ₹3.01 Cr |
| Wockhardt Ltd | Healthcare | 0.10% | ₹2.97 Cr |
| Wockhardt Ltd | Healthcare | 0.05% | ₹1.51 Cr |
| Net Receivables | Unspecified | 0.04% | ₹1.12 Cr |
| Mirae Asset Liquid Fund Direct- Growth | Unspecified | 0.01% | ₹0.24 Cr |
| Mirae Asset Liquid Fund Direct- Growth | Unspecified | 0.01% | ₹0.23 Cr |
| Mirae Asset Liquid Fund Direct- Growth | Unspecified | 0.01% | ₹0.23 Cr |
| Mirae Asset Liquid Fund Direct- Growth | Unspecified | 0.01% | ₹0.23 Cr |
| Mirae Asset Liquid Fund Direct- Growth | Unspecified | 0.01% | ₹0.23 Cr |
| Mirae Asset Liquid Fund Direct- Growth | Unspecified | 0.01% | ₹0.23 Cr |
| Mirae Asset Liquid Fund Direct- Growth | Unspecified | 0.01% | ₹0.23 Cr |
| Mirae Asset Liquid Fund Direct- Growth | Unspecified | 0.01% | ₹0.23 Cr |
| Mirae Asset Liquid Fund Direct- Growth | Unspecified | 0.01% | ₹0.23 Cr |
| Biocon Ltd | Healthcare | 0.01% | ₹0.20 Cr |
| Biocon Ltd | Healthcare | 0.01% | ₹0.20 Cr |
| Biocon Ltd | Healthcare | 0.01% | ₹0.19 Cr |
| Biocon Ltd | Healthcare | 0.01% | ₹0.19 Cr |
| Syngene International Ltd | Healthcare | 0.00% | ₹0.10 Cr |
| Syngene International Ltd | Healthcare | 0.00% | ₹0.09 Cr |
| Net Payables | Unspecified | -0.09% | ₹-2.66 Cr |
| Net Payables | Unspecified | -0.10% | ₹-2.77 Cr |
| Net Payables | Unspecified | -0.10% | ₹-2.77 Cr |
| Net Payables | Unspecified | -0.15% | ₹-4.03 Cr |
| Net Payables | Unspecified | -0.15% | ₹-4.22 Cr |
| Net Payables | Unspecified | -0.15% | ₹-4.22 Cr |
| Net Payables | Unspecified | -0.23% | ₹-6.12 Cr |
| Net Payables | Unspecified | -0.46% | ₹-13.14 Cr |
Top Equity Funds
| Fund Names | NAV | 3Yr | 5Yr | 52 weeks high |
|---|---|---|---|---|
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct - Growth |
₹41.64 | 29.16% | 18.03% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth |
₹38.45 | 28.07% | 17.00% | - |
| Aditya Birla Sun Life Pharma & Healthcare Fund Direct-growth |
₹34.77 | 26.36% | 16.00% | - |
| Aditya Birla Sun Life Pharma & Healthcare Fund Regular-growth |
₹31.40 | 24.68% | 14.39% | - |
Frequently Asked Questions
Mirae Asset Healthcare Fund Regular-idcw
What is the current AUM of Mirae Asset Healthcare Fund Regular-idcw?
As of Thu Jul 31, 2025, Mirae Asset Healthcare Fund Regular-idcw manages assets worth ₹2,908.2 crore
How has Mirae Asset Healthcare Fund Regular-idcw performed recently?
- 3 Months: 1.60%
- 6 Months: 14.07%
What is the long-term performance of Mirae Asset Healthcare Fund Regular-idcw?
- 3 Years CAGR: 21.20%
- 5 Years CAGR: 17.06%
- Since Inception: 20.55%
What is the portfolio composition of Mirae Asset Healthcare Fund Regular-idcw?
Equity: 99.72%, Debt: 0.01%, Others: 0.27%.
Who manages Mirae Asset Healthcare Fund Regular-idcw?
Mirae Asset Healthcare Fund Regular-idcw is managed by Vrijesh Kasera from Mirae Asset Mutual Fund.
When was the last dividend declared by Mirae Asset Healthcare Fund Regular-idcw?
Latest dividend was declared on 28 Jan 2026 at 19.20% of face value.
What is the market-cap allocation of Mirae Asset Healthcare Fund Regular-idcw?
Large Cap: 36.01%, Mid Cap: 34.91%, Small Cap: 29.09%.
Which are the top companies Mirae Asset Healthcare Fund Regular-idcw has invested in?
- Sun Pharmaceutical Industries Ltd – 13.06% of the fund's portfolio
- Sun Pharmaceutical Industries Ltd – 12.44% of the fund's portfolio
- Sun Pharmaceutical Industries Ltd – 12.01% of the fund's portfolio
- Sun Pharmaceutical Industries Ltd – 12.01% of the fund's portfolio
- Sun Pharmaceutical Industries Ltd – 11.77% of the fund's portfolio
Which are the major sectors Mirae Asset Healthcare Fund Regular-idcw focuses on?
- Healthcare – 870.47% of the fund's portfolio
- Materials – 11.07% of the fund's portfolio
- – 8.95% of the fund's portfolio
- Industrials – 5.91% of the fund's portfolio
- Unspecified – 3.59% of the fund's portfolio
Policybazaar does not endorse rates/returns or recommend any particular insurer, fund house, AMC (Asset Management Company), insurance and mutual fund product.
Please consult your financial advisor for an informed decision.
Past performance may not be indicative of future results.
The information presented on this page is not owned or generated by Policybazaar. The data has been collected from publicly available sources and online research. We do not claim any ownership or guarantee the accuracy, completeness, or timeliness of this information. It is shared solely for the informational purpose of the viewer and should not be considered as financial advice.
Policybazaar is not acting as a financial advisor, broker, or agent for any mutual fund mentioned here.
Mutual fund investments are subject to market risks. Please read all scheme-related documents carefully before investing.
Policybazaar shall not be held responsible or liable for any losses, damages, or decisions made based on the information provided on this page.
For a complete list of mutual funds registered in India, please refer to the Securities and Exchange Board of India (SEBI) website at www.sebi.gov.in. We do not sell, endorse, or recommend any mutual fund or investment product. For a complete list of mutual funds registered in India, please refer to the Securities and Exchange Board of India (SEBI) website at www.sebi.gov.in. We do not sell, endorse, or recommend any mutual fund or investment product.
For more details on risk factors, terms, and conditions, please read the sales brochure and benefit illustration carefully before concluding a sale.
Policybazaar is a registered Insurance Broker | Registration No. 742, Registration Code No. IRDA/ DB 797/ 19, Valid till 09/06/2024, License category- Direct Broker (Life & General) |CIN: U74999HR2014PTC053454 | Registered Office - Plot No.119, Sector - 44, Gurgaon, Haryana – 122001 |Visitors are hereby informed that their information submitted on the website may be shared with insurers. Product information is authentic and solely based on the information received from the insurers.©️ Copyright 2008-2025 policybazaar.com. All Rights Reserved
^Returns as on 10th Jan’25. Tata AIA Life Top 200 ULIP Fund has delivered 18% returns over the last 10 years. Past performance is not necessarily indicative of future results. This disclaimer is specifically regarding a ULIP fund and is not related to mutual funds. Source: Morningstar.





